CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-26 | Amoroso Michael Director | Grant or award | +11,797 | 144,365 | ||
| 2024-08-26 | Alvino Mark Director | Grant or award | +11,797 | 72,334 | ||
| 2024-08-26 | Alland Leila Director | Grant or award | +11,797 | 118,265 | ||
| 2024-08-13 | Crombez Eric Director | Grant or award | +11,044 | 11,044 | ||
| 2024-08-13 | Zeiher Bernhardt G Director | Grant or award | +11,044 | 11,044 | ||
| 2024-07-21 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −1,055 | $5.11 | $5K | 371,605 |
| 2024-07-08 | Wuchterl Donald A. Director | Grant or award | +23,611 | 102,714 | ||
| 2024-07-08 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +155,200 | 372,660 | ||
| 2024-07-08 | Silverstein Christine Berni Director | Grant or award | +23,611 | 85,674 | ||
| 2024-07-08 | O'Malley Brendan M. SVP, General Counsel | Grant or award | +102,689 | 280,364 | ||
| 2024-07-08 | Amoroso Michael Director | Grant or award | +23,611 | 132,568 | ||
| 2024-07-08 | Alvino Mark Director | Grant or award | +23,611 | 60,537 | ||
| 2024-07-08 | Alland Leila Director | Grant or award | +23,611 | 106,468 | ||
| 2024-07-08 | Seshadri Vishwas Chief Executive Officer | Grant or award | +424,000 | 922,936 | ||
| 2024-07-08 | Charles Faith L. Director | Grant or award | +23,611 | 101,934 | ||
| 2024-06-18 | Alvino Mark Director | Sale | −25,890 | $4.51 | $117K | 36,926 |
| 2024-06-18 | Silverstein Christine Berni Director | Sale | −25,821 | $4.51 | $116K | 62,063 |
| 2024-06-05 | Vazzano Joseph Walter Chief Financial Officer | Shares withheld for taxes | −16,408 | $4.52 | $74K | 217,460 |
| 2024-06-05 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −38,621 | $4.52 | $175K | 498,936 |
| 2024-06-05 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −10,951 | $4.52 | $49K | 177,675 |
Page 6 of 12 · 223 trades